SLDB - Solid Biosciences - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

167.1M

Cash

206.1M

Avg Qtr Burn

-22.84M

Short % of Float

12.30%

Insider Ownership

0.84%

Institutional Own.

94.56%

Qtr Updated

03/31/24

Drug Pipeline

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
SGT-003 Details Genetic disorder, Duchenne muscular dystrophy	Phase 1/2 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
SGT-501 (Cardiac Gene Therapy) Details Catecholaminergic Polymorphic Ventricular Tachycardia, Heart disease, Gene & Cell therapies	IND Submission	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
SGT-001 (Microdystrophin Gene Transfer) Details Genetic disorder, Muscle weakness, Muscle degeneration	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.